ScholarIQanswers from OpenAlex & ORCID
Kalevi Pyörälà
ResearcherPublications, citations & collaboration network
Kalevi Pyörälà is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Kalevi Pyörälà have?
ScholarIQindexed works
Kalevi Pyörälà has 300 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Kalevi Pyörälà have?
ScholarIQcitation count
Kalevi Pyörälà has 52,880 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Kalevi Pyörälà?
ScholarIQh-index
Kalevi Pyörälà has an h-index of 89 in OpenAlex.
What is the i10-index of Kalevi Pyörälà?
ScholarIQi10-index
Kalevi Pyörälà has an i10-index of 198 in OpenAlex.
What is the OpenAlex record for Kalevi Pyörälà?
ScholarIQopenalex
The OpenAlex for Kalevi Pyörälà is on the source record.
What are the most-cited papers on Kalevi Pyörälà?
ScholarIQmost cited works
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
Anders Olsson, John J.V. McMurray, G Thorgeirsson, Christian Spaulding, Jim Slattery, Kalevi Pyörälà, Ole Færgeman, R. Scott Wright, Katherine M. Berg, Lars Wilhelmsen, T.R. Pedersen, T. A. Miettinen, HD White, John Kjekshus, Michael Gnant
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Authors Task Force Members, L Rydén, Eberhard Standl, M. Bartnik, Greet Van den Berghe, John Betteridge, Menko‐Jan de Boer, Francesco Cosentino, Bengt Jönsson, Markku Laakso, K. Malmberg, Silvia G. Priori, Jan Östergren, J Tuomilehto, Inga S. Þráinsdóttir, Other Contributors, Ilse Vanhorebeek, Marco Stramba‐Badiale, Peter Lindgren, Qing Qiao, Silvia G. Priori, J J Blanc, Andrzej Budaj, A. John Camm, V. Dean, Jaap W. Deckers, Kenneth Dickstein, J. Lekakis, Keith McGregor, Marco Metra, João Morais, A. Osterspey, Juan Tamargo, José Luís Zamorano, Document Reviewers, Jaap W. Deckers, M Bertrand, B Charbonnel, Erland Erdmann, Ele Ferrannini, Allan Flyvbjerg, H. Gohlke, J.R.G. Juanatey, Ian Graham, Pedro Monteiro, Klaus G. Parhofer, Kalevi Pyörälà, Itamar Raz, Guntram Schernthaner, Massimo Volpe, David M. Wood
Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
Kalevi Pyörälà, Terje R. Pedersen, John Kjekshus, Ole Færgeman, Anders Olsson, Guðmundur Þorgeirsson, The Scandinavian Simvastatin Survival Study (4S) Group
Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria
K. Borch‐Johnsen, Andrew Neil, Beverley Balkau, Signe Holm Larsen, A Nissinen, Juha Pekkanen, Sirkka Keinänen‐Kiukaanniemi, Liisa Hiltunen, Sirkka‐Liisa Kivelä, Jaakko Tuomilehto, Pekka Jousilahti, Jaana Lindström, Marja Pyörälä, Kalevi Pyörälà, É. Eschwège, Giuseppe Gallus, Maria Paola Garancini, Anna Schranz, Robert J. Heine, Joost Dekker, Edith J. M. Feskens, Hans Lithell, Björn Zethelius, Markku Peltonen, Nigel Unwin, Nasir Ahmad, K. G. M. M. Alberti, M.M. Alberti, Jane Salier Eriksson, Qing Qiao
EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE
Daniel De Backer, Е. Амбросиони, K. Borch‐Johnsen, Carlos Brotons, Renata Cífková, Jean Dallongeville, S. Ebrahim, Ole Færgeman, Ian D. Graham, G. Mancia, V. Manger Cats, Kristina Orth‐Gomér, Joep Perk, Kalevi Pyörälà, José L. Rodicio, S Sans, Vedat Sansoy, U Sechtem, Sigmund Silber, Troels Thomsen, D. Wood